Withdrawal of oxyphenbutazone: what about phenylbutazone?
P
P
Biron
D002170:Canada; D004345:Drug Industry; D006801:Humans; D010113:Oxyphenbutazone / Q000009:adverse effects*; D010653:Phenylbutazone / Q000009:adverse effects*; D011634:Public Health
D010653:Phenylbutazone; D010113:Oxyphenbutazone